617 related articles for article (PubMed ID: 7693815)
1. Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells.
Patella V; Bouvet JP; Marone G
J Immunol; 1993 Nov; 151(10):5685-98. PubMed ID: 7693815
[TBL] [Abstract][Full Text] [Related]
2. Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells.
Patella V; Casolaro V; Björck L; Marone G
J Immunol; 1990 Nov; 145(9):3054-61. PubMed ID: 1698870
[TBL] [Abstract][Full Text] [Related]
3. Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE.
Patella V; Giuliano A; Bouvet JP; Marone G
J Immunol; 1998 Nov; 161(10):5647-55. PubMed ID: 9820545
[TBL] [Abstract][Full Text] [Related]
4. Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells.
Genovese A; Borgia G; Bouvet JP; Detoraki A; de Paulis A; Piazza M; Marone G
Int Arch Allergy Immunol; 2003 Dec; 132(4):336-45. PubMed ID: 14707465
[TBL] [Abstract][Full Text] [Related]
5. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
6. Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells.
Patella V; de Crescenzo G; Marino O; Spadaro G; Genovese A; Marone G
Int Arch Allergy Immunol; 1996 Sep; 111(1):23-9. PubMed ID: 8753840
[TBL] [Abstract][Full Text] [Related]
7. Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release.
Stellato C; Cirillo R; de Paulis A; Casolaro V; Patella V; Mastronardi P; Mazzarella B; Marone G
Anesthesiology; 1992 Nov; 77(5):932-40. PubMed ID: 1280014
[TBL] [Abstract][Full Text] [Related]
8. Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors.
Liu MC; Proud D; Lichtenstein LM; MacGlashan DW; Schleimer RP; Adkinson NF; Kagey-Sobotka A; Schulman ES; Plaut M
J Immunol; 1986 Apr; 136(7):2588-95. PubMed ID: 2419444
[TBL] [Abstract][Full Text] [Related]
9. Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells.
Casolaro V; Meliota S; Marino O; Patella V; de Paulis A; Guidi G; Marone G
J Pharmacol Exp Ther; 1993 Dec; 267(3):1375-85. PubMed ID: 7505332
[TBL] [Abstract][Full Text] [Related]
10. FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells.
de Paulis A; Cirillo R; Ciccarelli A; Condorelli M; Marone G
J Immunol; 1991 Apr; 146(7):2374-81. PubMed ID: 1706398
[TBL] [Abstract][Full Text] [Related]
11. Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization.
Patella V; Marinò I; Lampärter B; Arbustini E; Adt M; Marone G
J Immunol; 1995 Mar; 154(6):2855-65. PubMed ID: 7533185
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneous effects of protamine on human mast cells and basophils.
Patella V; Ciccarelli A; Lamparter-Schummert B; de Paulis A; Adt M; Marone G
Br J Anaesth; 1997 Jun; 78(6):724-30. PubMed ID: 9215027
[TBL] [Abstract][Full Text] [Related]
13. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells.
Genovese A; Patella V; De Crescenzo G; De Paulis A; Spadaro G; Marone G
Clin Exp Allergy; 1997 May; 27(5):559-67. PubMed ID: 9179431
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the anti-inflammatory effect of FK-506 on human mast cells.
de Paulis A; Cirillo R; Ciccarelli A; de Crescenzo G; Oriente A; Marone G
J Immunol; 1991 Dec; 147(12):4278-85. PubMed ID: 1721644
[TBL] [Abstract][Full Text] [Related]
15. Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors.
Lichtenstein LM; Kagey-Sobotka A; White JM; Hamilton RG
J Immunol; 1992 Jun; 148(12):3929-36. PubMed ID: 1376345
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs.
Marone G; Stellato C; Mastronardi P; Mazzarella B
Ann Fr Anesth Reanim; 1993; 12(2):116-25. PubMed ID: 7690200
[TBL] [Abstract][Full Text] [Related]
17. Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue.
Genovese A; Stellato C; Patella V; Lamparter-Schummert B; de Crescenzo G; Adt M; Marone G
Int J Clin Lab Res; 1996; 26(3):192-8. PubMed ID: 8905451
[TBL] [Abstract][Full Text] [Related]
18. Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release.
Stellato C; de Crescenzo G; Patella V; Mastronardi P; Mazzarella B; Marone G
J Allergy Clin Immunol; 1996 Mar; 97(3):838-50. PubMed ID: 8613641
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin superantigen protein L induces IL-4 and IL-13 secretion from human Fc epsilon RI+ cells through interaction with the kappa light chains of IgE.
Genovese A; Borgia G; Björck L; Petraroli A; de Paulis A; Piazza M; Marone G
J Immunol; 2003 Feb; 170(4):1854-61. PubMed ID: 12574351
[TBL] [Abstract][Full Text] [Related]
20. The antineoplastic bryostatins affect human basophils and mast cells differently.
Patella V; Casolaro V; Ciccarelli A; Pettit GR; Columbo M; Marone G
Blood; 1995 Mar; 85(5):1272-81. PubMed ID: 7532037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
